- Programm
- Horizon 2020 & sub-programmes
- Laufzeit
- 66 Monate (May 2018 – October 2023)
- Projektförderung
- ≈ €27 million
- Projektpartner
- 23
- Technologie-Reifegrad
- 0-2
- Projektwebsite
- Projektwebsite besuchen
Worum es geht
Diabetes is a global pandemic affecting around 60 million people in Europe. As a common and serious complication, Hypoglycaemia is particularly affecting people with diabetes on insulin therapy and can lead to cognitive decline, cardiovascular events and even death. Within Hypo-RESOLVE, 23 international players from academia, industry and civil society have joined forces to find better solutions to alleviate the burden and consequences of hypoglycaemia in diabetes.
Koordination
Dr Bastiaan de Galan
Stichting Radboud Universitair Medisch Centrum (RADBOUDUMC)
E-Mail sendenIhre EURICE-Kontakte
Explore THE COURT
Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.
THE COURT betreten